Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan

MeSH terms

• Antineoplastic Agents / adverse effects*
• Boronic Acids / adverse effects*
• Bortezomib
• Clinical Trials as Topic
• Cooperative Behavior*
• Drug Industry*
• Health Knowledge, Attitudes, Practice
• Humans
• Interdisciplinary Communication*
• Internet
• Japan
• Lung Diseases / chemically induced
• Lung Diseases / prevention & control*
• Mass Media*
• Medical Staff*
• Multiple Myeloma / drug therapy*
• Newspapers as Topic
• Patient Selection
• Periodicals as Topic
• Practice Guidelines as Topic
• Pyrazines / adverse effects*
• Risk Assessment
• Societies, Medical